Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Catherine Cargo

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Haematologica|January 29, 2026
Male sex adversely impacts survival and myeloid malignancy risk in MGUS: a real-world population-based studyEve Roman, Timothy Bagguley, Simon Crouch, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 4, 2019
Exploratory Study of MYD88 L265P, Rare NLRP3 Variants, and Clonal Hematopoiesis Prevalence in Patients With Schnitzler SyndromeShelly Pathak, Dorota M Rowczenio, Roger G Owen, et al.
British Journal of Haematology|November 12, 2025
COVID-19-related mortality in a real-world cohort of 18 883 patients with premalignant and malignant haematological neoplasms: An analysis from the UK's Haematological Malignancy Research NetworkAlexandra Smith, Clare Frobisher, Abraham Varghese, et al.
The Lancet. Haematology|December 22, 2023
Predicting cytopenias, progression, and survival in patients with clonal cytopenia of undetermined significance: a prospective cohort studyCatherine Cargo, Elsa Bernard, Tumas Beinortas, et al.
Nature|August 6, 2025
Excised DNA circles from V(D)J recombination promote relapsed leukaemiaZeqian Gao, James N F Scott, Matthew P Edwards, et al.
British Journal of Haematology|May 26, 2025
Mapping VEXAS-associated and rare UBA1 variants in the United Kingdom: Insights from patient cohorts and the general populationAna Martinez Rodriguez, Leon Chang, Dorota Rowczenio, et al.
Haematologica|April 10, 2025
Infections in lower-risk myelodysplastic syndromes - prevalence and risk factors: a report from the European MDS RegistryBente Houtman, Adele Taylor, Corine Van Marrewijk, et al.
British Journal of Haematology|February 18, 2026
Clinical outcomes of patients with lower risk myelodysplastic syndrome from EUMDS registry eligible for transplantation: Implications for transplantation strategiesAleksandar Savic, Adele Taylor, Pierre Fenaux, et al.
British Journal of Haematology|May 21, 2024
Inflammatory profile of lower risk myelodysplastic syndromesJoanne Topping, Adele Taylor, Fatima Nadat, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|November 4, 2024
Characterization of Genetic Landscape and Novel Inflammatory Biomarkers in Patients With Adult-Onset Still's DiseaseJoanne Topping, Leon Chang, Fatima Nadat, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Haematologica|January 29, 2026
Male sex adversely impacts survival and myeloid malignancy risk in MGUS: a real-world population-based studyEve Roman, Timothy Bagguley, Simon Crouch, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|July 4, 2019
Exploratory Study of MYD88 L265P, Rare NLRP3 Variants, and Clonal Hematopoiesis Prevalence in Patients With Schnitzler SyndromeShelly Pathak, Dorota M Rowczenio, Roger G Owen, et al.
British Journal of Haematology|November 12, 2025
COVID-19-related mortality in a real-world cohort of 18 883 patients with premalignant and malignant haematological neoplasms: An analysis from the UK's Haematological Malignancy Research NetworkAlexandra Smith, Clare Frobisher, Abraham Varghese, et al.
The Lancet. Haematology|December 22, 2023
Predicting cytopenias, progression, and survival in patients with clonal cytopenia of undetermined significance: a prospective cohort studyCatherine Cargo, Elsa Bernard, Tumas Beinortas, et al.
Nature|August 6, 2025
Excised DNA circles from V(D)J recombination promote relapsed leukaemiaZeqian Gao, James N F Scott, Matthew P Edwards, et al.
British Journal of Haematology|May 26, 2025
Mapping VEXAS-associated and rare UBA1 variants in the United Kingdom: Insights from patient cohorts and the general populationAna Martinez Rodriguez, Leon Chang, Dorota Rowczenio, et al.
Haematologica|April 10, 2025
Infections in lower-risk myelodysplastic syndromes - prevalence and risk factors: a report from the European MDS RegistryBente Houtman, Adele Taylor, Corine Van Marrewijk, et al.
British Journal of Haematology|February 18, 2026
Clinical outcomes of patients with lower risk myelodysplastic syndrome from EUMDS registry eligible for transplantation: Implications for transplantation strategiesAleksandar Savic, Adele Taylor, Pierre Fenaux, et al.
British Journal of Haematology|May 21, 2024
Inflammatory profile of lower risk myelodysplastic syndromesJoanne Topping, Adele Taylor, Fatima Nadat, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|November 4, 2024
Characterization of Genetic Landscape and Novel Inflammatory Biomarkers in Patients With Adult-Onset Still's DiseaseJoanne Topping, Leon Chang, Fatima Nadat, et al.
Pageof 3